Literature DB >> 3157001

Conservation of genome form but not sequence in the transcription antitermination determinants of bacteriophages lambda, phi 21 and P22.

N C Franklin.   

Abstract

Comparisons are made among DNA sequences upstream from terminators in both leftwards and rightwards early operons of related coliphages lambda, phi 21 and P22. These sequences include both left and right determinants of response to phage-coded antitermination proteins, "N", as well as the N structural genes themselves. Despite almost total disparity of DNA sequence, the three genomes can be discerned to include the same elements in the same order and spacing: downstream from the early left promoter are sequentially a site of recognition for host nusA protein, a dyad symmetry "nut" essential for N function in lambda, overlapping sites for processing of the transcript by RNAase III and then the N structural genes; downstream from the cro gene on the right are sites of nusA recognition and nut dyad symmetries homologous to those on the left. Because the N proteins of lambda, phi 21 and P22 do not for the most part complement each other, a specific site of N recognition has been postulated for each N-responding operon. The nut dyad symmetry qualifies as such a site, since the loop of the left dyad in lambda is marked by mutations that block N function leftwards, and since DNA sequences here show close homology between the loops of left and right dyads for each phage, but less if not little homology for different phages.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3157001     DOI: 10.1016/0022-2836(85)90325-0

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  23 in total

1.  Sequence of Shiga toxin 2 phage 933W from Escherichia coli O157:H7: Shiga toxin as a phage late-gene product.

Authors:  G Plunkett; D J Rose; T J Durfee; F R Blattner
Journal:  J Bacteriol       Date:  1999-03       Impact factor: 3.490

2.  Sequence of the genome of the temperate, serotype-converting, Pseudomonas aeruginosa bacteriophage D3.

Authors:  A M Kropinski
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

3.  Structural mimicry in the phage phi21 N peptide-boxB RNA complex.

Authors:  Christopher D Cilley; James R Williamson
Journal:  RNA       Date:  2003-06       Impact factor: 4.942

Review 4.  How the phage lambda N gene product suppresses transcription termination: communication of RNA polymerase with regulatory proteins mediated by signals in nascent RNA.

Authors:  A Das
Journal:  J Bacteriol       Date:  1992-11       Impact factor: 3.490

5.  Effects of all single base substitutions in the loop of boxB on antitermination of transcription by bacteriophage lambda's N protein.

Authors:  J H Doelling; N C Franklin
Journal:  Nucleic Acids Res       Date:  1989-07-25       Impact factor: 16.971

Review 6.  Antitermination mechanisms in rRNA operons of Escherichia coli.

Authors:  E A Morgan
Journal:  J Bacteriol       Date:  1986-10       Impact factor: 3.490

7.  The RNA-binding domain of bacteriophage P22 N protein is highly mutable, and a single mutation relaxes specificity toward lambda.

Authors:  Alexis I Cocozaki; Ingrid R Ghattas; Colin A Smith
Journal:  J Bacteriol       Date:  2008-09-26       Impact factor: 3.490

8.  Translational repression by a transcriptional elongation factor.

Authors:  H R Wilson; L Kameyama; J G Zhou; G Guarneros; D L Court
Journal:  Genes Dev       Date:  1997-09-01       Impact factor: 11.361

9.  An RNA enhancer in a phage transcriptional antitermination complex functions as a structural switch.

Authors:  L Su; J T Radek; L A Labeots; K Hallenga; P Hermanto; H Chen; S Nakagawa; M Zhao; S Kates; M A Weiss
Journal:  Genes Dev       Date:  1997-09-01       Impact factor: 11.361

Review 10.  Bacteriophage protein-protein interactions.

Authors:  Roman Häuser; Sonja Blasche; Terje Dokland; Elisabeth Haggård-Ljungquist; Albrecht von Brunn; Margarita Salas; Sherwood Casjens; Ian Molineux; Peter Uetz
Journal:  Adv Virus Res       Date:  2012       Impact factor: 9.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.